Date Time
Preparing for future pandemics with hi-tech lab
NTU Singapore and Pathnova Laboratories, a medical diagnostic company backed by Temasek Life Sciences Accelerator and headquartered in Temasek Life Sciences Laboratory, is contributing to Singapore’s COVID-19 diagnostic capability through its partnership in a new clinical diagnostic laboratory.
Amid the ongoing global COVID-19 situation, the lab plans to tap advanced technology like Artificial Intelligence (AI) and data analytics to innovate, boosting the country’s future pandemic response.
Situated at NTU Singapore’s Lee Kong Chian School of Medicine (LKCMedicine) Novena Campus, the NTU Clinical Diagnostic Laboratory was set up in April 2020 by a team of academic researchers, in support of the national effort to increase diagnostic testing capacity and commenced Covid-19 polymerase chain reaction (PCR) testing on 1 July 2020.